The CRISPR-Cas9 system is a bacterial immune mechanism that Charpentier, along with Jennifer Doudna, adapted for use in genome editing. This system allows for highly targeted modifications to the DNA of living organisms, making it an invaluable tool in biotechnology, medicine, and agriculture.